Literature DB >> 28149843

Gamma-glutamyl transferase and cardiovascular disease.

Gjin Ndrepepa1, Adnan Kastrati2.   

Abstract

Gamma-glutamyl transferase (GGT) is an enzyme located on the external surface of cellular membranes. GGT contributes in maintaining the physiological concentrations of cytoplasmic glutathione and cellular defense against oxidative stress via cleavage of extracellular glutathione and increased availability of amino acids for its intracellular synthesis. Increased GGT activity is a marker of antioxidant inadequacy and increased oxidative stress. Ample evidence suggests that elevated GGT activity is associated with increased risk of cardiovascular disease (CVD) such as coronary heart disease (CHD), stroke, arterial hypertension, heart failure, cardiac arrhythmias and all-cause and CVD-related mortality. The evidence is weaker for an association between elevated GGT activity and acute ischemic events and myocardial infarction. The risk for CVD or CVD-related mortality mediated by GGT may be explained by the close correlation of GGT with conventional CVD risk factors and various comorbidities, particularly non-alcoholic fatty liver disease, alcohol consumption, oxidative stress, metabolic syndrome, insulin resistance and systemic inflammation. The finding of GGT activity in atherosclerotic plaques and correlation of intra-plaque GGT activity with histological indexes of plaque instability may suggest a participation of GGT in the pathophysiology of CVD, particularly atherosclerosis. However, whether GGT has a direct role in the pathophysiology of CVD or it is an epiphenomenon of coexisting CVD risk factors or comorbidities remains unknown and Hill's criteria of causality relationship between GGT and CVD are not fulfilled. The exploration whether GGT provides prognostic information on top of the information provided by known cardiovascular risk factors regarding the CVD or CVD-related outcome and exploration of molecular mechanisms of GGT involvement in the pathophysiology of CVD and eventual use of interventions to reduce circulating GGT activity remain a duty of future studies.

Entities:  

Keywords:  Cardiovascular disease (CVD); gamma-glutamyl transferase (GGT); mortality; prognosis

Year:  2016        PMID: 28149843      PMCID: PMC5233492          DOI: 10.21037/atm.2016.12.27

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  93 in total

1.  Serum gamma-glutamyl transferase and risk of heart failure in the community.

Authors:  Ravi Dhingra; Philimon Gona; Thomas J Wang; Caroline S Fox; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-06-10       Impact factor: 8.311

2.  Images in cardiovascular medicine. Human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity.

Authors:  Aldo Paolicchi; Michele Emdin; Erri Ghliozeni; Eugenio Ciancia; Claudio Passino; George Popoff; Alfonso Pompella
Journal:  Circulation       Date:  2004-03-23       Impact factor: 29.690

Review 3.  Redox homeostasis and antioxidant signaling: a metabolic interface between stress perception and physiological responses.

Authors:  Christine H Foyer; Graham Noctor
Journal:  Plant Cell       Date:  2005-07       Impact factor: 11.277

4.  Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.

Authors:  Douglas S Lee; Jane C Evans; Sander J Robins; Peter W Wilson; Irene Albano; Caroline S Fox; Thomas J Wang; Emelia J Benjamin; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-11-09       Impact factor: 8.311

5.  Association between serum gamma-glutamyltransferase and C-reactive protein.

Authors:  Duk-Hee Lee; David R Jacobs
Journal:  Atherosclerosis       Date:  2005-02       Impact factor: 5.162

Review 6.  Liver enzymes and risk of all-cause mortality in general populations: a systematic review and meta-analysis.

Authors:  Setor K Kunutsor; Tanefa A Apekey; Dorothy Seddoh; John Walley
Journal:  Int J Epidemiol       Date:  2014-02       Impact factor: 7.196

7.  Gamma-glutamyltransferase and prognosis in patients with stable coronary heart disease followed over 8 years.

Authors:  L P Breitling; N C Grandi; H Hahmann; B Wüsten; D Rothenbacher; H Brenner
Journal:  Atherosclerosis       Date:  2010-01-11       Impact factor: 5.162

8.  The value of gamma-glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes.

Authors:  S G Wannamethee; L Lennon; A G Shaper
Journal:  Atherosclerosis       Date:  2008-03-10       Impact factor: 5.162

9.  gamma-Glutamyl transpeptidase: a single copy gene in the rat and a multigene family in the human genome.

Authors:  A Pawlak; O Lahuna; F Bulle; A Suzuki; N Ferry; S Siegrist; N Chikhi; M N Chobert; G Guellaen; Y Laperche
Journal:  J Biol Chem       Date:  1988-07-15       Impact factor: 5.157

10.  Nonalcoholic Fatty Liver Disease Is Associated With Ventricular Arrhythmias in Patients With Type 2 Diabetes Referred for Clinically Indicated 24-Hour Holter Monitoring.

Authors:  Alessandro Mantovani; Antonio Rigamonti; Stefano Bonapace; Bruna Bolzan; Matteo Pernigo; Giovanni Morani; Lorenzo Franceschini; Corinna Bergamini; Lorenzo Bertolini; Filippo Valbusa; Riccardo Rigolon; Isabella Pichiri; Giacomo Zoppini; Enzo Bonora; Francesco Violi; Giovanni Targher
Journal:  Diabetes Care       Date:  2016-05-23       Impact factor: 19.112

View more
  31 in total

1.  Peri-operative derangement in liver function tests in older patients with neck of femur fracture.

Authors:  J Powell; A Michael
Journal:  Osteoporos Int       Date:  2021-01-18       Impact factor: 4.507

2.  Association of Low Molecular Weight Plasma Aminothiols with the Severity of Coronavirus Disease 2019.

Authors:  Evgeny Vladimirovich Kryukov; Alexander Vladimirovich Ivanov; Vladimir Olegovich Karpov; Valery Vasil'evich Alexandrin; Alexander Mikhaylovich Dygai; Maria Petrovna Kruglova; Gennady Ivanovich Kostiuchenko; Sergei Petrovich Kazakov; Aslan Amirkhanovich Kubatiev
Journal:  Oxid Med Cell Longev       Date:  2021-09-18       Impact factor: 6.543

3.  ROLE OF THIOLS IN OXIDATIVE STRESS.

Authors:  Shahid P Baba; Aruni Bhatnagar
Journal:  Curr Opin Toxicol       Date:  2018-03-21

4.  Lean polycystic ovary syndrome (PCOS): an evidence-based practical approach.

Authors:  Sehar Toosy; Ravinder Sodi; Joseph M Pappachan
Journal:  J Diabetes Metab Disord       Date:  2018-11-13

5.  A clinical model to predict fibrosis on liver biopsy in paediatric subjects with nonalcoholic fatty liver disease.

Authors:  Sakil Kulkarni; Nadia Naz; Hongjie Gu; Janis M Stoll; Michael D Thompson; Brian J DeBosch
Journal:  Clin Obes       Date:  2021-06-09

6.  Application of a Novel Prediction Model for Predicting 2-Year Risk of Non-Alcoholic Fatty Liver Disease in the Non-Obese Population with Normal Blood Lipid Levels: A Large Prospective Cohort Study from China.

Authors:  Liwei Ji; Xintian Cai; Yang Bai; Tao Li
Journal:  Int J Gen Med       Date:  2021-06-28

7.  Alanine Aminotransferase and Gamma-Glutamyl Transpeptidase Predict Histologic Improvement in Pediatric Nonalcoholic Steatohepatitis.

Authors:  Kimberly P Newton; Joel E Lavine; Laura Wilson; Cynthia Behling; Miriam B Vos; Jean P Molleston; Philip Rosenthal; Tamir Miloh; Mark H Fishbein; Ajay K Jain; Karen F Murray; Jeffrey B Schwimmer
Journal:  Hepatology       Date:  2020-11-30       Impact factor: 17.298

8.  Effects of Carbamazepine and Valproate on Serum Aspartate Aminotransferase, Alanine Aminotransferase and Gamma - Glutamyltransferase in Children.

Authors:  Feriha Hadzagic-Catibusic; Edo Hasanbegovic; Melika Melunovic; Smail Zubcevic; Sajra Uzicanin
Journal:  Med Arch       Date:  2017-08

9.  Nonalcoholic fatty liver disease as a predictor of atrial fibrillation: a systematic review and meta-analysis.

Authors:  Yaqiong Zhou; Chenglin Lai; Chunrong Peng; Mingyue Chen; Bolin Li; Xiaoyun Wang; Jingjing Sun; Chaofeng Sun
Journal:  Postepy Kardiol Interwencyjnej       Date:  2017-09-25       Impact factor: 1.426

10.  Gamma-Glutamyltransferase and Risk of Acute Coronary Syndrome in Young Chinese Patients: A Case-Control Study.

Authors:  Yuli Huang; Jianjin Luo; Xinyue Liu; Yu Wu; You Yang; Wensheng Li; Weibiao Lv; Yunzhao Hu
Journal:  Dis Markers       Date:  2018-09-02       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.